Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

48.92
Delayed Data
As of Aug 31
 -0.36 / -0.73%
Today’s Change
43.57
Today|||52-Week Range
57.42
+7.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$128.7B

Company Description

Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following segments: Pharmaceuticals, Human Vaccines, Animal Health, and Others. The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products. This segment also includes equity affiliates and joint ventures with pharmaceutical business activities. The Human Vaccines segment includes research, development, production and marketing of vaccines. The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species. The Others segment includes all activities that do not qualify as reportable segments under IFRS 8 “Operating Segments”; it also includes the effects of retained commitments in respect of divested businesses. The company was founded in 1994 and is headquartered in Paris, France.

Contact Information

Sanofi
54, rue La Boétie
Paris Ile-de-france 75008
P:(315) 377-4000
Investor Relations:
(315) 377-4545

Employees

Shareholders

Mutual fund holders4.93%
Other institutional4.73%
Individual stakeholders--

Top Executives

Olivier BrandicourtChief Executive Officer
Jérôme ContamineChief Financial Officer & EVP-Finance
Elias E. ZerhouniPresident-Global Research & Development
Andrew PurcellVice President & Head-US Diabetes Business Unit
Rafick G. HeneinVP, Global Brand Leader-Toujeo & Diabetes